HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Late effects of childhood malignancies seen in Western Australia.

Abstract
Eighty-nine pediatric oncology patients, in remission and off treatment for at least 4 years, were reviewed annually in the Late Effects Clinic of Princess Margaret Hospital for Children in Perth, Western Australia. Interval from time of diagnosis to follow-up ranged from 4 to 23 years (mean 10.8 years). Acute lymphoblastic leukemia (ALL) (40%) and Wilms' tumor (27%) were the most common primary malignancies in this group. Late sequelae included musculoskeletal abnormalities (23 children), growth hormone deficiency (11), second tumors (9), learning difficulties (7), puberty and fertility problems (4), and hypothyroidism (4). These complications were most often related to radiation therapy. The need for prolonged, regular follow-up of survivors of childhood malignancy for early detection of late sequelae and subsequent intervention is stressed.
AuthorsG M Crooks, G S Baron-Hay, G C Byrne, F G Cameron, P Hookings, E J Keogh, A MacKellar, P J Price, B G Stuckey, S A Campbell
JournalThe American journal of pediatric hematology/oncology (Am J Pediatr Hematol Oncol) Vol. 13 Issue 4 Pg. 442-9 ( 1991) ISSN: 0192-8562 [Print] United States
PMID1785671 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Growth Hormone
Topics
  • Adolescent
  • Child
  • Child, Preschool
  • Follow-Up Studies
  • Growth Hormone (deficiency)
  • Humans
  • Infant
  • Infant, Newborn
  • Learning Disabilities (etiology)
  • Musculoskeletal Diseases (etiology)
  • Neoplasms (complications)
  • Neoplasms, Second Primary (etiology)
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma (complications)
  • Retrospective Studies
  • Time Factors
  • Western Australia (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: